Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06256588
Title A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma (JADE)
Acronym JADE
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
GSK Investigational Site Los Angeles California 90095 United States Details
GSK Investigational Site Stockton California 95204 United States Details
GSK Investigational Site Farmington Connecticut 06030-1628 United States Details
GSK Investigational Site New Haven Connecticut 06520 United States Details
GSK Investigational Site Washington District of Columbia 20010 United States Details
GSK Investigational Site Lexington Kentucky 40536 United States Details
GSK Investigational Site Worcester Massachusetts 01655-0002 United States Details
GSK Investigational Site Saint Louis Missouri 63110 United States Details
GSK Investigational Site Charleston South Carolina 29425 United States Details
GSK Investigational Site Greenville South Carolina 29607 United States Details
GSK Investigational Site Germantown Tennessee 38138 United States Details
GSK Investigational Site Capital Federal Buenos Aires C1417DTN Argentina Details
GSK Investigational Site Ciudad Autonoma de Buenos Aires Buenos Aires 1426 Argentina Details
GSK Investigational Site Viedma Río Negro R8500ACE Argentina Details
GSK Investigational Site Rosario Santa Fe S2002 Argentina Details
GSK Investigational Site San Miguel de Tucumán Tucumán T4000GTB Argentina Details
GSK Investigational Site Ciudad Autonoma de Buenos Aires C1437GZT Argentina Details
GSK Investigational Site Cordoba 5000 Argentina Details
GSK Investigational Site San Juan J5400 Argentina Details
GSK Investigational Site Blacktown New South Wales 2148 Australia Details
GSK Investigational Site Herston Queensland 4029 Australia Details
GSK Investigational Site Ballarat Victoria 3350 Australia Details
GSK Investigational Site Geelong Victoria 3220 Australia Details
GSK Investigational Site Melbourne Victoria 3004 Australia Details
GSK Investigational Site Douglas 4814 Australia Details
GSK Investigational Site Bruxelles 1200 Belgium Details
GSK Investigational Site Charleroi 6000 Belgium Details
GSK Investigational Site Edegem 2650 Belgium Details
GSK Investigational Site Gent 9000 Belgium Details
GSK Investigational Site Yvoir 5530 Belgium Details
GSK Investigational Site Salvador Bahía 41253-190 Brazil Details
GSK Investigational Site Salvador Bahía 41825-010 Brazil Details
GSK Investigational Site Vitória Espírito Santo 29043-260 Brazil Details
GSK Investigational Site Belo Horizonte Minas Gerais 30110-022 Brazil Details
GSK Investigational Site Porto Alegre Rio Grande Do Sul 90610-000 Brazil Details
GSK Investigational Site Florianopolis Santa Catarina 88020-210 Brazil Details
GSK Investigational Site Joinville Santa Catarina 89201-260 Brazil Details
GSK Investigational Site Barretos São Paulo 14784-400 Brazil Details
GSK Investigational Site Sao Jose Do Rio Preto São Paulo 15090-200 Brazil Details
GSK Investigational Site São Paulo 01246-000 Brazil Details
GSK Investigational Site Hamilton Ontario L8V 5C2 Canada Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Montreal Quebec H3T 1E2 Canada Details
GSK Investigational Site Prague 10034 Czechia Details
GSK Investigational Site Praha 8 180 81 Czechia Details
GSK Investigational Site Praha 150 08 Czechia Details
GSK Investigational Site Zlin 76275 Czechia Details
GSK Investigational Site Caen Cedex 5 14075 France Details
GSK Investigational Site Dijon Cedex 21079 France Details
GSK Investigational Site Marseille 13005 France Details
GSK Investigational Site Poitiers cedex 86021 France Details
GSK Investigational Site Rennes Cedex 35042 France Details
GSK Investigational Site Valenciennes 59300 France Details
GSK Investigational Site Vandœuvre-lès-Nancy Cedex 54519 France Details
GSK Investigational Site Stuttgart Baden-Wuerttemberg 70174 Germany Details
GSK Investigational Site Augsburg Bayern 86156 Germany Details
GSK Investigational Site Erlangen Bayern 91054 Germany Details
GSK Investigational Site Straubing Bayern 94315 Germany Details
GSK Investigational Site Hannover Niedersachsen 30625 Germany Details
GSK Investigational Site Essen Nordrhein-Westfalen 45147 Germany Details
GSK Investigational Site Berlin 12351 Germany Details
GSK Investigational Site Berlin 13353 Germany Details
GSK Investigational Site Hamburg 22087 Germany Details
GSK Investigational Site Athens 12462 Greece Details
GSK Investigational Site Efkarpia 564 29 Greece Details
GSK Investigational Site Larissa 41100 Greece Details
GSK Investigational Site Győr 9023 Hungary Details
GSK Investigational Site Kaposvar 7400 Hungary Details
GSK Investigational Site Nyíregyháza H-4400 Hungary Details
GSK Investigational Site Salgótarján 3100 Hungary Details
GSK Investigational Site Napoli Campania 80131 Italy Details
GSK Investigational Site Roma Lazio 00161 Italy Details
GSK Investigational Site Roma Lazio 00168 Italy Details
GSK Investigational Site Savona Liguria 17100 Italy Details
GSK Investigational Site Milano Lombardia 20133 Italy Details
GSK Investigational Site Milano Lombardia 20141 Italy Details
GSK Investigational Site Pavia Lombardia 27100 Italy Details
GSK Investigational Site Rozzano (MI) Lombardia 20089 Italy Details
GSK Investigational Site Aichi 464-8681 Japan Details
GSK Investigational Site Chiba 260-8717 Japan Details
GSK Investigational Site Chiba 277-8577 Japan Details
GSK Investigational Site Ehime 791-0280 Japan Details
GSK Investigational Site Fukuoka 812-8582 Japan Details
GSK Investigational Site Hokkaido 060-8648 Japan Details
GSK Investigational Site Hyogo 650-0017 Japan Details
GSK Investigational Site Iwate 028-3695 Japan Details
GSK Investigational Site Kanagawa 236-0004 Japan Details
GSK Investigational Site Kyoto 612-8555 Japan Details
GSK Investigational Site Miyagi 981-1293 Japan Details
GSK Investigational Site Niigata 951-8520 Japan Details
GSK Investigational Site Osaka 541-8567 Japan Details
GSK Investigational Site Saitama 350-1298 Japan Details
GSK Investigational Site Shizuoka 411-8777 Japan Details
GSK Investigational Site Tokyo 104-0045 Japan Details
GSK Investigational Site Tokyo 113-8519 Japan Details
GSK Investigational Site Tokyo 152-8902 Japan Details
GSK Investigational Site Tokyo 160-0023 Japan Details
GSK Investigational Site Tottori 683-8504 Japan Details
GSK Investigational Site Busan 49241 Korea, Republic of Details
GSK Investigational Site Busan 602-030 Korea, Republic of Details
GSK Investigational Site Seoul 03722 Korea, Republic of Details
GSK Investigational Site Seoul 06351 Korea, Republic of Details
GSK Investigational Site Seoul 110 744 Korea, Republic of Details
GSK Investigational Site Suwon 16247 Korea, Republic of Details
GSK Investigational Site Guadalajara Jalisco 44650 Mexico Details
GSK Investigational Site Oaxaca de Juarez Oaxaca 68020 Mexico Details
GSK Investigational Site Ciudad de Mexico 06760 Mexico Details
GSK Investigational Site Ciudad de Mexico 11510 Mexico Details
GSK Investigational Site Bergen 5021 Norway Details
GSK Investigational Site Oslo 0379 Norway Details
GSK Investigational Site Tromsø 9038 Norway Details
GSK Investigational Site Bielsko-Biala 43-300 Poland Details
GSK Investigational Site Gliwice 44-102 Poland Details
GSK Investigational Site Katowice 40-514 Poland Details
GSK Investigational Site Koszalin 75-581 Poland Details
GSK Investigational Site Olsztyn 10-228 Poland Details
GSK Investigational Site Przemysl 37-700 Poland Details
GSK Investigational Site Siedlce 08-110 Poland Details
GSK Investigational Site Warszawa 04-141 Poland Details
GSK Investigational Site Coimbra 3000-075 Portugal Details
GSK Investigational Site Faro 8000-386 Portugal Details
GSK Investigational Site Lisboa 1649-035 Portugal Details
GSK Investigational Site Lisboa 1998-018 Portugal Details
GSK Investigational Site Matosinhos 4464-509 Portugal Details
GSK Investigational Site Porto 4200-072 Portugal Details
GSK Investigational Site Porto 4200-319 Portugal Details
GSK Investigational Site Vila Nova de Gaia 4434-502 Portugal Details
GSK Investigational Site Pitesti Arges 110283 Romania Details
GSK Investigational Site Bucuresti 013823 Romania Details
GSK Investigational Site Cluj-Napoca 400015 Romania Details
GSK Investigational Site Craiova 200094 Romania Details
GSK Investigational Site Craiova 200542 Romania Details
GSK Investigational Site Iasi 700483 Romania Details
GSK Investigational Site Oradea 410469 Romania Details
GSK Investigational Site Suceava 720214 Romania Details
GSK Investigational Site Timisoara 300239 Romania Details
GSK Investigational Site Göteborg SE-413 45 Sweden Details
GSK Investigational Site Stockholm SE-171 64 Sweden Details
GSK Investigational Site Uppsala SE-751 85 Sweden Details
GSK Investigational Site Changhua 500 Taiwan Details
GSK Investigational Site Kaohsiung 833 Taiwan Details
GSK Investigational Site Taichung 40447 Taiwan Details
GSK Investigational Site Taipei 100 Taiwan Details
GSK Investigational Site Ankara 06100 Turkey Details
GSK Investigational Site Antalya 07025 Turkey Details
GSK Investigational Site Istanbul 34662 Turkey Details
GSK Investigational Site Sutton Surrey SM2 5PT United Kingdom Details
GSK Investigational Site Wolverhampton West Midlands WV10 0QP United Kingdom Details
GSK Investigational Site Edinburgh EH4 2XU United Kingdom Details
GSK Investigational Site London SW3 6JJ United Kingdom Details
GSK Investigational Site Nottingham, NG5 1PB United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field